Lee, J. S., Yoon, I. S., Lee, M. S., Cha, E. Y., Thuong, P. T., Diep, T. T., & Kim, J. R. (2023). Anticancer activity of pristimerin in epidermal growth factor receptor 2-positive SKBR3 human breast cancer cells. The Pharmaceutical Society of Japan.
Trích dẫn kiểu ChicagoLee, Jin Sun, In Sang Yoon, Myung Sun Lee, Eun Young Cha, Phuong Thien Thuong, Trinh Thi Diep, và Je Ryong Kim. Anticancer Activity of Pristimerin in Epidermal Growth Factor Receptor 2-positive SKBR3 Human Breast Cancer Cells. The Pharmaceutical Society of Japan, 2023.
Trích dẫn MLALee, Jin Sun, et al. Anticancer Activity of Pristimerin in Epidermal Growth Factor Receptor 2-positive SKBR3 Human Breast Cancer Cells. The Pharmaceutical Society of Japan, 2023.
Cảnh báo: Các trích dẫn này có thể không phải lúc nào cũng chính xác 100%.